GEP20043347B - Use of Pyrazolopyrimidinones for Treatment of Impotence - Google Patents

Use of Pyrazolopyrimidinones for Treatment of Impotence

Info

Publication number
GEP20043347B
GEP20043347B GEAP2003005385A GEP20043347B GE P20043347 B GEP20043347 B GE P20043347B GE AP2003005385 A GEAP2003005385 A GE AP2003005385A GE P20043347 B GEP20043347 B GE P20043347B
Authority
GE
Georgia
Prior art keywords
impotence
treatment
pyrazolopyrimidinones
radicals
essence
Prior art date
Application number
Inventor
Peter Ellis
Nicholas Kenneth Terrett
Original Assignee
Peizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peizer Inc filed Critical Peizer Inc
Publication of GEP20043347B publication Critical patent/GEP20043347B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. Technical Result Increase in efficiency of impotence treatment. 2. Essence A compound of the formula, radicals of which are provided in the description, and pharmaceutical composition on its base, their use in medicaments production for treating and prevention of erectile dysfunction in a male human. 3. Field of Application Medicine.
GEAP2003005385 2002-10-22 2003-12-29 Use of Pyrazolopyrimidinones for Treatment of Impotence GEP20043347B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64690102A 2002-10-22 2002-10-22

Publications (1)

Publication Number Publication Date
GEP20043347B true GEP20043347B (en) 2004-10-11

Family

ID=45468236

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP2003005385 GEP20043347B (en) 2002-10-22 2003-12-29 Use of Pyrazolopyrimidinones for Treatment of Impotence

Country Status (1)

Country Link
GE (1) GEP20043347B (en)

Similar Documents

Publication Publication Date Title
IL267381A (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
TW200518752A (en) Combinations of drugs for the treatment of neoplasms
EG25822A (en) Quinolinyl-pyrrolopyrazoles
NO993520L (en) Dosage forms and methods for better erectile dysfunction
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
GEP20053688B (en) Substituted-Triazolopyrimidines as Anticancer Agents
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
BR0316753A (en) Treatment method for sexual dysfunction
HK1085667A1 (en) Non-nucleoside reverse transcriptase inhibitors
CY1108401T1 (en) PYRROLOIMIDAZOLO PRODUCERS, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE AND USE AS A NOOTROPIC FACTOR
MX347237B (en) Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction.
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
HK1068606A1 (en) Novel aminobenzoephenones
WO2005011572A3 (en) Combination of drugs for the treatment of neoplasms
MXPA05012358A (en) Pharmaceutical combination comprising modafinil and another drug.
EP1503748A4 (en) Drugs for mitigating taxane-induced neurotoxicity
HUP0400924A3 (en) Use of 2,5-dihydroxybenzenesulfphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction
HK1044467A1 (en) Use of polycyclic thiazole systems for producing medicaments for preventing or treating obesity
GEP20043347B (en) Use of Pyrazolopyrimidinones for Treatment of Impotence
GEP20043348B (en) Pyrazolopyrimidinone Antianginal Agents
MXPA04001268A (en) Carbonic anhydrase inhibitor.
PT1572686E (en) Anthranilic acid amide derivatives and their pharmaceutical use
MXPA05008490A (en) New combinations and new use of selected pharmaceutically active compounds.
UA38697A (en) Method for treating generalized parodontitis
AU2002317182A1 (en) Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction